三七总皂苷注射液治疗急性脑梗死30例临床研究  

作　　者：张臻 李梅 

机构地区：[1]山东淄博市颜山医院,255201

出　　处：《中国社区医师（医学专业）》2012年第21期172-173,共2页

摘　　要：目的:观察三七总皂苷注射液治疗急性脑梗死的疗效及安全性。方法:将起病48小时内的急性脑梗死患者60例随机分为治疗组和对照组,分别给予三七总皂苷注射液及普通治疗。结果:治疗组比对照组治愈率(P<0.05)、总有效率(P<0.01)明显提高。结论:本疗法疗效理想,应用方便,不良反应少。Objective：To study the effect and the safety of panax natoginsen on the treat- ment of acute cerebral infarction. Methods： 60 case with cerebral infareition within 48 hours of onset were randomly divided into panax notiginsan treated group and control group（ treated with conventional therapy）. Results：Both the cure rate and the total ef- fective rate were significantly higher in the panax notoginsan treated group than in the control group（P 〈0.05 or P 〈0.01 ）. Con- clusion：Not only the treatment of acute cer- ebral infarction with panax notognsan is ef- fective, convenient and safe, but also has lit- tle side -effects. It could be widely used in clinical practice.

关 键 词：脑梗死 急性 皂苷类 三七 

分 类 号：R512.5[医药卫生—内科学]